National measles guidelines
How to manage cases of suspected measles: what patient details to take, who to notify and assessing risk of disease spreading in close contacts.
Applies to England
Documents
Details
The national measles guidelines for health professionals covers:
- how to decide if a suspected case of measles is ‘likely’ or ‘unlikely’
- case management – what lab tests should be done and the importance of oral fluid testing on all suspected cases
- measles control – identifying vulnerable contacts and assessing their need for post-exposure prophylaxis
As detailed in the guidance, the measles warn and inform letter can be used where it is necessary to contact a number of people who have been potentially exposed to a case of measles – please see the guidelines for further information about this.
The measles factsheet can be given to individuals to give them information about:
- what measles is and how it spreads
- symptoms and complications of measles
- vaccination
- what to do if you have measles
Translations of warn and inform letters
These translated warn and inform letters open as Word documents.
- Albanian
- Amharic
- Arabic
- Bengali
- Cantonese
- Dari
- Farsi
- French
- Gujarati
- Hindi
- Italian
- Lithuanian
- Mandarin
- Nepali
- Pahari Pothwari
- Pashto
- Polish
- Portuguese
- Punjabi Shahmukhi
- Punjabi Gurmukhi
- Romanian
- Shona
- Slovak
- Somali
- Spanish
- Sylheti
- Tagalog
- Tamil
- Tigrinya
- Turkish
- Ukranian
- Urdu
Translations of factsheets
These translated factsheets open as PDF documents.
Last updated
-
Added the easy read warn and inform letter.
-
Added translations of the warn and inform letters and factsheets.
-
Clarification of responsibilities for risk assessment in healthcare settings page 37. Further product information added on immunoglobulin product, Cuvitru, page 35.
-
Added factsheet and updated letter.
-
Updated guidance see page 3 for change history.
-
Updated guidance, including additional section on defining the time window for receiving post-exposure prophylaxis (PEP).
-
Updated guidance.
-
Added latest version of guidelines.
-
Updated to reflect revised clinical advice.
-
First published.
Update history
2024-07-25 09:23
Guidance updated – see page 3 for change history.
2024-06-14 09:30
Added the translated easy read warn and inform letters.
2024-05-10 10:35
Added measles easy ready factsheet.
2024-04-11 16:12
Updated National measles guidelines – see page 3 for change history.
2024-03-20 14:18
Added the easy read warn and inform letter.
2024-03-08 16:12
Added translations of the warn and inform letters and factsheets.
2024-02-28 12:30
Clarification of responsibilities for risk assessment in healthcare settings page 37.Further product information added on immunoglobulin product, Cuvitru, page 35.
2024-02-16 15:11
Added factsheet and updated letter.
2024-02-01 14:11
Updated guidance see page 3 for change history.
2024-01-17 11:33
Updated guidance, including additional section on defining the time window for receiving post-exposure prophylaxis (PEP).
2023-10-27 11:12
Updated guidance.